Comparative bioavailability study of two ibuprofen preparations after oral administration in healthy volunteers

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 9, 2006, Pages 647-651

  Bienert, Agnieszka ^a   Szkutnik Fiedler, Danuta ^a   Dyderski, Stanisław ^a   Grześkowiak, Edmund ^a   Drobnik, Leon ^a   Wolc, Anna ^b   Sławińska, Urszula ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Anti inflammatories, non steroidal; CAS 15687 27 1; Ibuprofen, bioavailability, bioequivalence

Indexed keywords

2 (1,4 ISOBUTYLPHENYL) PROPIONIC ACID; CAS 15687 27 1; IBUPROFEN; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM; DRUG FORMULATION; FOOD AND DRUG ADMINISTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; ULTRAVIOLET RADIATION;

EID: 33749498224     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296766     Document Type: Article

References (10)

1. De Brabander, C., Vervaet, C., Van Bortel, L. et al., Bioavailability of ibuprofen from hot-melt extruded mini-matrices. Int. J. Pharm. 271, 77 (2004)
2. Portolés, A., Vargas, E., Pharmacokinetic Study of a New Ibuprofen 600 mg Plus Codeine 30 mg Combination Versus Ibuprofen or Codeine Alone in Single Oral Doses in Healthy Volunteers. Clin. Drug Invest. 22, 41 (2002)
3. Busson, M., Update on ibuprofen [review]. J. Int. Med. Res. 14, 53 (1986)
4. AHFS Drug Information 2005. American Society of Health - System Pharmacists; Ibuprofen: 1985-1991
5. Chassard, D., Geneteau, A., Gualano, V. et al., Bioequivalence Study of Two Ibuprofen Formulations Administered Intravenously in Healthy Male Volunteers. Clin. Drug Invest. 24, 739 (2004)
6. Van Overmeire, B., Smets, K., Lecoutere, D. et al., A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N. Engl. J. Med. 343, 674 (2000)
7. Van Overmeire, B., Follens, I., Hartmann, S. et al., Treatment of patent ductus arteriosus with ibuprofen. Arch. Dis. Child 76, F179 (1997)
8. The European Agency for the Evaluation of Medicinal Products Committee Proprietary Medical Products; CPMP/EWP/QWP/1401/98: Note for guidance on the investigation of bioavailability and bioequivalence, London, 26 July 2001
9. Rustum Abu, M., Assay of Ibuprofen in Human Plasma by Rapid and Sensitive Reversed-Phase-Performance Liquid Chromatography. Applications to a Single Dose Pharmacokinetic Study. J. Chromatogr. Sci. 29, 16 (1991)
10. Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), July 2002 BP